关键信息
-
基因名
S100A7A
- 应用
-
别名
S100A7A；S100A15；S100A7L1；Protein S100-A7A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q86SG5
-
表达区间
2-101aa
-
氨基酸序列
SNTQAERSIIGMIDMFHKYTGRDGKIEKPSLLTMMKENFPNFLSACDKKGIHYLATVFEKKDKNEDKKIDFSEFLSLLGDIAADYHKQSHGAAPCSGGSQ
-
分子量
13.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
S100A7A, a member of the S100 protein family, is a calcium-binding protein primarily expressed in epithelial cells and has been implicated in various biological processes. Its dysregulation has been observed in several pathological conditions, including inflammatory diseases and certain types of cancer, making it of significant interest in biomedical research. Recent studies have highlighted its role as a potential biomarker and therapeutic target due to its involvement in modulating inflammation, cell proliferation, and apoptosis. The recombination and characterization of S100A7A protein allow researchers to elucidate its functional mechanisms in cellular signaling pathways and immune responses. By producing recombinant S100A7A, scientists can study its structure-function relationship, interactions with other proteins, and effects on cellular behavior. This research not only enhances our understanding of S100A7A's biological roles but also paves the way for developing novel diagnostic and therapeutic strategies targeting diseases associated with S100A7A dysregulation. As the advances in recombinant protein techniques continue to evolve, S100A7A stands out as a promising candidate for further exploration in the context of both basic and applied biomedical sciences.
